| Filed On | Filing |
|---|---|
| 28 Apr 2025 |
Form 4/A: Leonard Braden Michael, 10% owner
Bought 20,407 shares ($103K) · Bought 16,593 shares ($86.1K) |
| 21 Sep 2022 |
Form 4/A: Beckman Richard, Chief Medical Officer
Received 33,333 shares as a grant or award |
| 20 May 2020 |
Form 4/A: Gasmi Mehdi, Director
Received 88,496 shares as a grant or award · Gave up 46,976 shares to cover exercise price or tax ($590K) · Received 10,000 shares by exercise or conversion ($48K) · 1 more |
| 08 May 2020 |
Form 4/A: Patterson Leone D, Director
Gave up 10,985 shares to cover exercise price or tax ($112K) |
| 14 Feb 2020 |
Form 4/A: Gasmi Mehdi, Director
Gave up 15,494 shares to cover exercise price or tax ($159K) |
| 10 Feb 2020 |
Form 4/A: Gasmi Mehdi, Director
Received 88,496 shares as a grant or award |
| 10 Feb 2020 |
Form 4/A: Patterson Leone D, Director
Sold 40,000 shares ($429K) |
| 25 Oct 2019 |
Form 4/A: Finer Mitchell H., Former Director
Granted 0 Stock Option (Right to Buy) |
| 05 Jun 2015 |
Form 4/A: Gasmi Mehdi, VP, Pharmaceutical Development
Received 500 shares by exercise or conversion ($1.38K) · Sold 500 shares ($19K) |
Loading...